Cargando…
The Research Progress of Direct KRAS G12C Mutation Inhibitors
Abstract: KRAS mutations have long been considered undruggable. However, a series of direct KRAS mutation inhibitors have been developed since the switch II pocket was discovered recently. This review will summarize progress in the development of direct KRAS G12C mutation inhibitors, current relevan...
Autores principales: | Yang, Ai, Li, Min, Fang, Mingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262225/ https://www.ncbi.nlm.nih.gov/pubmed/34257597 http://dx.doi.org/10.3389/pore.2021.631095 |
Ejemplares similares
-
Corrigendum: The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2022) -
EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021) -
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras
(LSL-G12V) Driven Lung Cancer Mouse Model
por: Meder, Lydia, et al.
Publicado: (2021) -
Brief Research Report Regional Difference in TRAF2 and TRAF3 Gene Mutations in Colon Cancers
por: Moon, Seong Won, et al.
Publicado: (2021) -
HMGB1 Translocation is Associated with Tumor-Associated Myeloid Cells and Involved in the Progression of Fibroblastic Sarcoma
por: Chen, Huoying, et al.
Publicado: (2021)